{"product_id":"incresina-duo-alogliptina-metformina-tabletas-12-5mg-500mg-con-56","title":"Incresina Duo (Alogliptin\/Metformin) Tablets 12.5mg\/500mg With 56","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eAntidiabetics\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eDPP-4 Inhibitors and Metformin\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eIncresina Duo\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eAlogliptin and Metformin\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003eTablets 12.5Mg\/500Mg, pack of 56 tablets\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eEurofarma\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eIncresina Duo is indicated for the treatment of type 2 diabetes mellitus in adults. Its use is recommended in patients whose hyperglycemia is not adequately controlled with metformin alone, or in combination with other antidiabetic drugs. It is used as part of a treatment regimen that includes an adequate diet and physical exercise. The combination of Alogliptin and Metformin acts in different ways to control blood glucose levels, improving insulin sensitivity and reducing glucose production by the liver. This medication can be used as dual therapy or in combination with insulin.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach tablet contains: 12.5 mg of Alogliptin and 500 mg of Metformin.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eIncresina Duo is contraindicated in patients with hypersensitivity to any of the components of the formula, in those with severe kidney disease, decompensated heart failure, diabetic ketoacidosis, and in cases of lactic acidosis. Its use is not recommended in pregnant or breastfeeding women without medical supervision.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003ePrecautions should be taken in patients with a history of kidney, liver, or heart disease. It is important to monitor kidney function before starting treatment and periodically during its use. Patients should be informed about the signs and symptoms of lactic acidosis and should be instructed to seek medical attention if they experience these symptoms. Additionally, the possibility of adjusting the dose should be considered in case of changes in kidney function or other factors that may affect the effectiveness of the treatment.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in a cool, dry place, protected from light and out of reach of children. Do not use after the expiration date indicated on the package.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Eurofarma","offers":[{"title":"Default Title","offer_id":46299749843169,"sku":"7891317019419","price":1618.06,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/optimized_incresina_duo_alogliptinametformina_tabletas_125mg500mg_con_56_7891317019419_1.jpg?v=1768495448","url":"https:\/\/wecarepharma.mx\/en\/products\/incresina-duo-alogliptina-metformina-tabletas-12-5mg-500mg-con-56","provider":"WeCare Pharma","version":"1.0","type":"link"}